Background: The purpose of this study was to elucidate the incidence and predictors of ischemic stroke or recurrent transient ischemic attack (TIA) during acute hospitalization in patients with TIA. Methods: We carried out a multicenter retrospective study to clarify the characteristics of in-patients with TIA. The subjects of this study were TIA patients admitted to 13 stroke hospitals within 7 days after onset between 2008 and 2009. TIA was defined as focal neurologic symptoms ascribable to a vascular etiology lasting less than 24 h. We investigated the incidence and predictors of ischemic events including ischemic stroke or recurrent TIA during hospitalization. Results: A total of 464 patients with TIA (292 men, 69 ± 13 years) were registered. Of those, 400 (86.2%) were admitted within 24 h of TIA onset. The mean length of hospital stay was 13 days. During hospitalization, 8 patients had ischemic strokes and 26 had recurrent TIAs. The leading subtype of 8 ischemic strokes was small vessel disease (n = 3) followed by cardioembolism (n = 2). Multiple logistic regression analysis showed that hypertension (OR: 3.41; 95% CI: 1.23-12.3), MRI-diffusion-weighted image positivity (OR: 2.49; 95% CI: 1.15-5.25), and hemiparesis (OR: 2.30; 95% CI: 1.02-5.88) were independently associated with ischemic events during hospitalization. Conclusions: In this study, 1.7% of patients with TIA had ischemic stroke during acute hospitalization, and the most common subtype was small vessel disease. Subsequent ischemic stroke and recurrent TIA were associated with hypertension, positive DWI findings, and hemiparesis.

1.
Johnston SC, Rothwell PM, Nguyen-Huynh MN, Giles MF, Elkins JS, Bernstein AL, Sidney S: Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007;369:283-292.
2.
Calvet D, Touzé E, Oppenheim C, Turc G, Meder JF, Mas JL: DWI lesions and TIA etiology improve the prediction of stroke after TIA. Stroke 2009;40:187-192.
3.
Uehara T, Minematsu K; Japan TIA Research Group 09-11: Clinical practice of transient ischemic attack in Japan: a questionnaire survey to stroke teaching hospitals certified by Japan Stroke Society (in Japanese, English abstract). Jpn J Stroke 2010;32:710-718.
4.
Redgrave JNE, Coutts SB, Schulz UG, Briley D, Rothwell PM: Systematic review of associations between the presence of acute ischemic lesions on diffusion-weighted imaging and clinical predictors of early stroke risk after transient ischemic attack. Stroke 2007;38:1482-1488.
5.
Sheehan OC, Kyne L, Kelly LA, Hannon N, Marnane M, Merwick A, McCormack PM, Duggan J, Moore A, Moroney J, Daly L, Harris D, Horgan G, Williams EB, Kelly PJ: Population-based study of ABCD2 score, carotid stenosis, and atrial fibrillation for early stroke prediction after transient ischemic attack: the North Dublin TIA study. Stroke 2010;41:844-850.
6.
Giles MF, Albers GW, Amarenco P, Arsava MM, Asimos A, Ay H, Calvet D, Coutts S, Cucchiara BL, Demchuk AM, Johnston SC, Kelly PJ, Kim AS, Labreuche J, Lavallee PC, Mas JL, Merwick A, Olivot JM, Purroy F, Rosamond WD, Sciolla R, Rothwell PM: Addition of brain infarction to the ABCD2 score (ABCD2I): a collaborative analysis of unpublished data on 4574 patients. Stroke 2010;41:1907-1913.
7.
Merwick A, Albers GW, Amarenco P, Arsava EM, Ay H, Calvet D, Coutts SB, Cucchiara BL, Demchuk AM, Furie KL, Giles MF, Labreuche J, Lavallée PC, Mas JL, Olivot JM, Purroy F, Rothwell PM, Saver JL, Sheehan OC, Stack JP, Walsh C, Kelly PJ: Addition of brain and carotid imaging to the ABCD2 score to identify patients at early risk of stroke after transient ischaemic attack: a multicenter observational study. Lancet Neurol 2010;9:1060-1069.
8.
Purroy F, Montaner J, Rovira A, Delgado P, Quintana M, Alvarez-Sabín J: Higher risk of further vascular events among transient ischemic attack patients with diffusion-weighted imaging acute ischemic lesions. Stroke 2004;35:2313-2319.
9.
Purroy F, Montaner J, Molina CA, Delgado P, Ribo M, Varez-Sabin J: Patterns and predictors of early risk of recurrence after transient ischemic attack with respect to etiologic subtypes. Stroke 2007;38:3225-3229.
10.
Coutts SB, Simon JE, Eliasziw M, Sohn CH, Hill MD, Barber PA, Palumbo V, Kennedy J, Roy J, Gagnon A, Scott JN, Buchan AM, Demchuk AM: Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging. Ann Neurol 2005;57:848-854.
11.
Prabhakaran S, Chong JY, Sacco RL: Impact of abnormal diffusion-weighted imaging results on short-term outcome following transient ischemic attack. Arch Neurol 2007;64:1105-1109.
12.
Ay H, Arsava EM, Johnston SC, Vangel M, Schwamm LH, Furie KL, Koroshetz WJ, Sorensen AG: Clinical- and imaging-based prediction of stroke risk after transient ischemic attack: the CIP model. Stroke 2009;40:181-186.
13.
Miyagi T, Uehara T, Kimura K, Okada Y, Hasegawa Y, Tanahashi N, Suzuki A, Takagi S, Nakagawara J, Arii K, Nagahiro S, Ogasawara K, Nagao T, Uchiyama S, Matsumoto M, Iihara K, Toyoda K, Minematsu K: Examination timing and lesion patterns in diffusion-weighted magnetic resonance imaging of patients with classically defined transient ischemic attack. J Stroke Cerebrovasc Dis 2013;22:e310-e316.
14.
Kimura K, Kazui S, Minematsu K, Yamaguchi T; Japan Multicenter Stroke Investigators' Collaboration (J-MUSIC): Analysis of 16,922 patients with acute ischemic stroke and transient ischemic attack in Japan. Cerebrovasc Dis 2004;18:47-56.
15.
Giles M, Rothwell PM: Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 2007;6:1063-1072.
16.
Lavallée PC, Meseguer E, Abboud H, Cabrejo L, Olivot JM, Simon O, Mazighi M, Nifle C, Niclot P, Lapergue B, Klein IF, Brochet E, Steg PG, Lesèche G, Labreuche J, Touboul PJ, Amarenco P: A transient ischemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol 2007;6:953-960.
17.
Sanders LM, Srikanth VK, Jolley DJ, Sundararajan V, Psihogios H, Wong K, Ramsay D, Phan TG: Monash transient ischemic attack triaging treatment: safety of a transient ischemic attack mechanism-based outpatient model of care. Stroke 2012;43:2936-2941.
18.
Rothwell PM, Warlow CP: Timing of TIAs preceding stroke: time window for prevention is very short. Neurology 2005;64:817-820.
19.
Chandratheva A, Mehta Z, Geraghty OC, Marquardt L, Rothwell OM, Oxford Vascular Study: Population-based study of risk and predictors of stroke in the first few hours after a TIA. Neurology 2009;72:1941-1947.
20.
Coull AJ, Lovett JK, Rothwell PM: Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ 2004;328:326.
21.
Nakajima M, Hirano T, Naritomi H, Minamatsu K: Symptom progression or fluctuation in transient ischemic attack patients predicts subsequent stroke. Cerebrovasc Dis 2009;29:221-227.
22.
Mori M, Okada Y, Yosimura S, Matsushita T, Miyazaki Y, Makihara N, Wakugawa Y, Yasaka M: ABCD2 score to identify individuals on admission at high early risk of stroke after transient ischemic attack. Jpn J Stroke 2011;33:25-30.
23.
Ohara T, Yamamoto Y, Nagakane Y, Tanaka E, Morii F, Koizumi T: Classification of etiologic subtypes for transient ischemic attacks: clinical significance of lacunar transient ischemic attack. Rinsho Shinkeigaku 2011;51:406-411.
24.
Warrior L, Prabhakaran P: Transient ischemic attack evaluation models: hospitalization, same-day clinics, or rapid evaluation units. Am J Ther 2011;18:45-50.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.